Stay updated on Cirmtuzumab Consolidation after Venetoclax in CLL Clinical Trial

Sign up to get notified when there's something new on the Cirmtuzumab Consolidation after Venetoclax in CLL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cirmtuzumab Consolidation after Venetoclax in CLL Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The page shows a revision update from v3.3.1 to v3.3.2; there is no change to the study content, eligibility, endpoints, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T17:12:56.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    Publication notes now indicate that PubMed publications are automatically filled from PubMed and may not be about the study, and the revision label has been updated to v3.3.1 from v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T13:39:10.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Removal of the funding/operational status notice; the page continues to display the study details, eligibility criteria, and study plan.
    Difference
    0.4%
    Check dated 2025-11-17T06:27:12.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    The update shows revised last update timestamps and minor layout adjustments; core study details (title, conditions, eligibility criteria, and outcomes) are unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T01:10:01.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    Update introduces version v3.2.0 and a government-operating status notice; it also removes the genetic resource for B-cell chronic lymphocytic leukemia.
    Difference
    5%
    Check dated 2025-10-05T10:10:44.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0.
    Difference
    0.1%
    Check dated 2025-09-28T03:18:00.000Z thumbnail image

Stay in the know with updates to Cirmtuzumab Consolidation after Venetoclax in CLL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cirmtuzumab Consolidation after Venetoclax in CLL Clinical Trial page.